Gizmodo
Kotaku
Lifehacker
PEDESTRIAN.TV
image/svg+xml
bi-logo
bi-logo-refreshsuite-
Toggle navigation
Search Icon
A magnifying glass icon.
Tech
Money & Markets
Briefing
Ideas
Executive Life
Research
Makes Cents
Reviews
Globe Icon
An icon of the world globe.
Edition
AUS
Edition
AUSTRALIA
UNITED STATES
INTERNATIONAL
DEUTSCHLAND
ESPAÑA
FRANCE
INDIA
ITALY
JAPAN
MALAYSIA
NEDERLAND
NORDIC
POLSKA
SINGAPORE
SOUTH AFRICA
Search Icon
A magnifying glass icon.
Globe Icon
An icon of the world globe.
EDITION
AUSTRALIA
UNITED STATES
INTERNATIONAL
DEUTSCHLAND
ESPAÑA
FRANCE
INDIA
ITALY
JAPAN
MALAYSIA
NEDERLAND
NORDIC
POLSKA
SINGAPORE
SOUTH AFRICA
Tagged With GILD
Immunomedics soars 106% after Gilead agrees to acquire the cancer-drug company for $21 billion
Matthew Fox
Sep 15, 2020, 1:01 AM
2 biotech stocks plummet more than 25% after the FDA rejects their drug applications
Matthew Fox
Aug 20, 2020, 12:43 AM
Gilead soars 11% after reporting positive news on potential coronavirus treatment
Carmen Reinicke
Apr 29, 2020, 11:50 PM
US stocks close mixed as virus drug report offsets oil-market surge
Ben Winck
Apr 24, 2020, 6:11 AM
Gilead tanks 9% on report its coronavirus drug doesn't help patients
Ben Winck
Apr 24, 2020, 4:44 AM
Arcus Biosciences spikes 99% on reports of $10 billion Gilead partnership
Ben Winck
Apr 17, 2020, 5:58 AM
One Wall Street firm says approval for Gilead's experimental coronavirus treatment is a coin-flip bet at best — but still thinks you should buy the stock right now
Ben Winck
Mar 6, 2020, 3:55 AM
A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.
Ben Winck
Feb 29, 2020, 12:24 AM
Drug developer Gilead soars to 16-month high after WHO official says its experimental treatment is best shot for fighting coronavirus
Ben Winck
Feb 25, 2020, 5:20 AM